| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 7,759 | 18,082 | 16,338 | 41,369 | | Cost of Revenue | 14,455 | (6,182) | 6,182 | 11,689 | | | Gross Profit | (6,696) | 24,264 | 10,156 | 29,680 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (6,489) | 14,695 | 3,835 | 5,083 | | Non Recurring |
-
| 1,243 | 29,402 | 36,970 | | Others | 5,646 | 7,858 | 11,324 | 17,661 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (5,853) | 468 | (34,405) | (30,034) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 4,572 | (31,600) | 10,222 | 127,282 | | Earnings Before Interest And Taxes | (1,281) | (31,132) | (24,183) | 97,248 | | Interest Expense | 3,919 | 4,224 | 3,911 | 4,410 | | Income Before Tax | (5,200) | (35,356) | (28,094) | 92,838 | | Income Tax Expense | (441) | 916 | (10,952) | 33,728 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (4,759) | (36,272) | (17,142) | 59,110 | | | Non-recurring Events | | Discontinued Operations | 276 | 46,091 | 279 |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (4,483) | 9,819 | (16,863) | 59,110 | | Preferred Stock And Other Adjustments | (2,696) | (2,696) | (2,669) | (2,696) | | | Net Income Applicable To Common Shares | ($7,179) | $7,123 | ($19,532) | $56,414 |
|
1.52% Nasdaq 0.00%
Income Statement
